CD274 and angiosarcoma: Prior studies of angiosarcoma noted high rates of ATRX mutation, high TMB, and PDL-1 positivity, particularly among head and neck angiosarcoma [8], while we observed a DDR alteration rate of 25% and ATRX alteration rate of 13% among angiosarcoma.